Compare Tripar Multivision Plus Tbk. (RAAM) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tripar Multivision Plus Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Tripar Multivision Plus Tbk. trades at Rp202 (market cap 1.38T, 1.56M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume). The key difference: Tripar Multivision Plus Tbk. is the larger of the two by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 1.56M). Which is the better fit depends on your goals.
| RAAM | RSCH | |
|---|---|---|
Market Cap | 1.38T | 742B |
Volume | 1.56M | 29.45M |
Lot | 15.58K | 294.49K |
Turnover | 314.38M | 8.14B |
Average Price | 201.83 | 276.35 |
Value | 314.38M | 8.14B |
Indicative Equilibrium Price | 202 | 270 |
Indicative Equilibrium Volume | 16 | 103 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tripar Multivision Plus Tbk.
PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →
